Combo Dual Therapy Stent: Pivotal trial started

OrbusNeich began the single-blind, U.S. and Japanese pivotal HARMONEE trial to compare its Combo Dual Therapy Stent vs. an everolimus-eluting stent in 572 patients with ischemic coronary disease and N...